Bone Marrow Transplant Procedures at GoBroad Hospitals in China

China's 1st hospital to perform haploidentical bone marrow transplant for thalassemia. Treats leukaemia, aplastic anaemia, and rare blood disorders with outcomes that exceed international benchmarks.

Bone Marrow Transplant at GoBroad Healthcare Group
4,000+ bone marrow transplants completed, covering paediatric cases from 1 month of age to adult cases.

Why International Patients Choose Gobroad for Bone Marrow Transplant

Bone marrow transplant in China with outcomes that lead globally for thalassemia, leukaemia, and aplastic anaemia
GoBroad holds the world's highest published survival outcomes for thalassemia bone marrow transplant. From your first enquiry, a dedicated international patient coordinator arranges your scan review, cost estimate, and airport transfers so nothing about travelling to China for a transplant is left unplanned.
  • Performed the world's first haploidentical stem cell transplant for thalassemia in 1999, led by Professor Li Chunfu.
  • Thalassemia TDH transplantation achieves 97.1% engraftment, 96.5% overall survival, and 94.3% thalassemia-free survival.
  • For Diamond-Blackfan Anaemia, TDH transplantation achieves 100% overall survival and 100% disease-free survival at 5 years.
  • Salvage transplantation is performed in 85% of indicated cases.
  • Written cost estimate provided before you travel, with no financial commitment required before clinical review of your case.

Technology Used for Bone Marrow Transplant at GoBroad Healthcare Group

The quality of the environment, diagnostic tools, and cell processing systems used directly affects your risk of infection, engraftment success, and long-term recovery.
  • Level-100 laminar flow rooms
  • Siemens 3.0T MRI
  • Siemens 64-slice CT
  • CAR-T cell manufacturing platform
  • Lentiviral vector gene therapy
  • Next-generation sequencing (NGS)

Bone Marrow Transplant Procedures at GoBroad Hospitals in China

Each transplant protocol at GoBroad is individually matched to the patient's disease type, age, treatment history, and donor availability, following internationally published clinical standards.
Allogeneic bone marrow transplant Uses matched or haploidentical donor stem cells to rebuild healthy blood production after cancer or blood disorder treatment. Inquire
TDH haploidentical transplant Removes T-cells causing graft-versus-host disease, making half-matched donor transplant safe without long-term immunosuppression. Inquire
Autologous Stem Cell Transplant Uses the patient's own stem cells, collected before high-dose treatment and reinfused to rebuild the blood system. Inquire
Salvage transplantation A bone marrow transplant for patients who have relapsed or failed prior transplant or treatment. Inquire
Bone marrow transplant for thalassemia A curative transplant replacing defective blood-forming cells, freeing patients from lifelong transfusions. Inquire
CAR-T bridging to transplant Uses CAR-T therapy to achieve remission first, then consolidates with transplant for long-term survival. Inquire

Care Journey for International Patients

Your cancer treatment journey made simple and stress-free in 5 easy steps
  • 1
    Online inquiry & medical files upload Share your medical reports for review. It takes less than a minute.
  • 2
    Doctor review & treatment plan Within 24hrs you will receive treatment options & a preliminary plan before travel.
  • 3
    Travel coordination We arrange your visa, flights, and accommodation.
  • 4
    Treatment phase Full care under a dedicated case manager.
  • 5
    Start your treatment Begin treatment with full support from our care team.

Frequently Asked Questions

Have a question? Our support team is here to guide you through each step of your treatment journey with personal care and attention.
Can GoBroad treat me if my first bone marrow transplant failed?

Yes. GoBroad performs second allogeneic and salvage transplantation for patients whose first transplant has relapsed or failed.

  • Second transplant: 1-year OS 80.6%, 1-year DFS 72.5%, NRM just 2.3%
  • Salvage transplant: performed in 85% of eligible cases, 50% success rate
  • Every protocol designed individually based on disease profile and prior treatment history

These outcomes exceed published international figures for this high-risk group.

Does GoBroad perform bone marrow transplants for children?

GoBroad is one of China's most experienced paediatric bone marrow transplant centres.

  • 1,223 paediatric HSCTs performed (July 2018 to January 2024) at the Chunfu Children's Institute
  • 69.77% were haploidentical procedures
  • Transplants performed from as young as 1 month of age
  • Paediatric thalassemia OS: 97.84%, published in Blood and Leukemia
  • Conditions treated: thalassemia major, ALL, AML, JMML, and rare blood disorders
  • Led by Professor Chunfu Li in strategic cooperation with Mayo Clinic
How do I contact the international patient support team for bone marrow transplant at GoBroad?

Bone marrow transplant appointments and treatment planning at GoBroad in China are handled through the International Patient Care team at My1Health.

The team arranges specialist consultations, remote medical record review, cost estimates, visa documentation, and airport transfers, all before you travel.

How long will I need to stay in China for a bone marrow transplant?

Stay duration depends on the transplant type.

Transplant TypeEstimated Stay
Allogeneic transplant2 to 3 months
Autologous transplant4 to 6 weeks
Paediatric thalassemia transplantVaries by engraftment progress

A personalised treatment itinerary is prepared before you travel. Remote monitoring after you return home means repeat trips are rarely needed.

What happens if complications arise after I return home?

Post-transplant support continues after you leave China.

  • Your dedicated coordinator remains your point of contact
  • The transplant team is available via online video consultation
  • Blood results and bone marrow assessments can be reviewed remotely
  • GoBroad advises your local medical team on management
  • Return visit scheduling is arranged by the coordinator if further treatment is needed

You are not left to manage recovery alone from abroad.

What is the bone marrow transplant success rate at GoBroad?

GoBroad holds some of the strongest published bone marrow transplant outcomes in the world.

ConditionKey Outcome
Thalassemia (TDH protocol)97.1% engraftment, 96.5% OS, GTFS exceeding 80%
Diamond-Blackfan Anaemia100% OS and 100% DFS at 5 years
Second allogeneic transplant1-year OS 80.6%, NRM just 2.3%

These results surpass international benchmarks and have been published in peer-reviewed journals

Will GoBroad review my diagnosis and scans before I travel?

Yes. A remote review of your diagnosis, pathology reports, bone marrow biopsy, and imaging is arranged before you travel. An online consultation with the relevant transplant specialist follows, and a written cost estimate is provided. No financial commitment is required before you have full clinical clarity on your case.

Talk to a Patient Support Specialist